With the recent emergence of antibody reproducibility being questioned in many headlines, it is comforting to know that R&D Systems has taken antibody validation and reproducibility seriously for over 30 years. Our highly selective development and validation criteria ensure only the best antibodies end up in your hands. This white paper shows real data examples of some of the stringent steps we take.
Read this article to learn about our antibody validation process:
Specificity and Sensitivity Testing
Release Decision and Quality Control
Download Development of Validated Monoclonal Antibodies White Paper